HEK293T cells were cultured in complete growth media (10% FCS, Pen/strep, L-Glutamine in DMEM) until 60 to 70% confluent on a 10 cm dish. The medium was then replaced with Opti-MEM (supplemented with L-Glutamine and 5% FCS, no antibiotics) for two hours. Cells were then transfected with Lipofectamine 3000 according to the manufacturer ́s instructions. Briefly, a15 solution with Lipofectamine 3000 and a solution with a mix of 18 μg of the following plasmids were separately prepared in Opti-MEM: pMDL g/p RRE, pRSV-REV, pLenti-GFP and a plasmid encoding the spike proteins of SARS-CoV-2 or VSV-G. Plasmid ratio for pMDL g/p RRE, pRSV-REV, the spike protein plasmid and pLenti-GFP is 1:1:1:2, respectively. The P3000 reagent was then added to the mix. After 5 minutes, the DNA mix was added to Lipofectamine20 solution and the mix was left for 20 minutes at room temperature. The mix was then added to the cells for 6 hours. Cell medium was then changed to normal growth medium (without antibiotics). 24 and 48 hours after transfection, the medium was collected, centrifuged at 1000 x g for 5 minutes, and filtered through a 0.45 μm filter. The medium was centrifuged at 65,000 x g with a SW28 rotor for 3 hours over a cushion of 10% sucrose prepared in PBS. The pellet was finally25 resuspended in TBS buffer containing 5% bovine serum albumin overnight at 4°C, aliquoted and frozen at -80°C
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Cantuti-Castelvetri, L, Teesalu, T, Balistreri, G and Simons, M(2022). Production of SARS-CoV-2 S-pseudotyped lentiviral particles. Bio-protocol Preprint. bio-protocol.org/prep2014.
Cantuti-Castelvetri, L., Ojha, R., Pedro, L. D., Djannatian, M., Franz, J., Kuivanen, S., Meer, F. V. D., Kallio, K., Kaya, T., Anastasina, M., Smura, T., Levanov, L., Szirovicza, L., Tobi, A., Kallio-Kokko, H., Österlund, P., Joensuu, M., Meunier, F. A., Butcher, S. J., Winkler, M. S., Mollenhauer, B., Helenius, A., Gokce, O., Teesalu, T., Hepojoki, J., Vapalahti, O., Stadelmann, C., Balistreri, G. and Simons, M.(2020). Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science 370(6518). DOI: 10.1126/science.abd2985
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.